news

April 12, 2019

Tumor Mutation Burden Study Shows Viability of In-House Testing

As laboratories increasingly look to bring advanced molecular testing in-house, the results of a new retrospective clinical research study show that tumor mutation burden... Read More
April 12, 2019

Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360

Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health... Read More
April 12, 2019

SomaLogic announces new collaboration with Janssen Research & Development

SomaLogic, Inc. has announced that it has entered into a collaborative agreement with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies... Read More
April 12, 2019

FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia

The FH Foundation recently announced the launch of the FIND HoFH program to identify individuals at risk for homozygous familial hypercholesterolemia (HoFH). The goal... Read More
April 12, 2019

SOPHiA GENETICS Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection

SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight... Read More
April 3, 2019

PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health Management

Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating for a healthier world, launched GenePrism: Actionable Insights, a new genetic... Read More
April 3, 2019

Pat Basu, MD, MBA, named President and Chief Executive Officer of Cancer Treatment Centers of America

BOCA RATON, Fla., April 3, 2019 /PRNewswire/ — Pat A. Basu, MD, MBA, an accomplished health care executive and entrepreneur, has been appointed President... Read More
April 3, 2019

Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer

• CE-IVD marked software as a medical device that aids clinicians to more easily interpret NGS oncology tests • Classifies detected variants in accordance... Read More
April 2, 2019

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

WALTHAM, Mass. and CAMBRIDGE, Mass., March 24, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Brammer... Read More
April 2, 2019

Multi-Year Agreement Broadens Uses of Real-World Evidence and Accelerates Precision Oncology Innovations

    Bristol-Myers Squibb and Concerto HealthAI, a market leader in oncology-specific Real-World Data (RWD) and advanced Artificial Intelligence (AI)-enabled insight solutions for Real-World... Read More
January 30, 2019

Scientists Engineer New CRISPR Platform for DNA Targeting

CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox. A team that includes the scientist who first... Read More
January 30, 2019

Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to “Get Iron Informed”

Daiichi Sankyo, Inc. today announced a partnership with dancer, choreographer and TV host Carrie Ann Inaba on Get Iron Informed, a campaign to raise... Read More
January 30, 2019

New Study to Focus on Unique Needs of Acute Myeloid Leukemia Patients

The Cancer Support Community (CSC), a global nonprofit, is launching a unique research study focused on individuals diagnosed with Acute Myeloid Leukemia (AML), a... Read More
January 30, 2019

PHC Holdings Signs Agreement to Acquire Anatomical Pathology Business from Thermo Fisher Scientific

PHC Holdings Corporation (headquarters: Tokyo, Japan, hereafter PHCHD) has announced that it has signed a definitive agreement with Thermo Fisher Scientific Inc. (NYSE: TMO,... Read More
January 30, 2019

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2018. Fourth quarter 2018 results: Revenue of $867... Read More
January 30, 2019

ArcherDX Acquires Baby Genes, a Genetics-Based Personalized Medicine Company

ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, is pleased to announce the... Read More
January 23, 2019

Diaceutics Opens Asian Hub to Capitalize on Growing Market

Diaceutics, the diagnostics data analytics and implementation services company, today announces that it is opening a new regional hub in Asia. With more than... Read More
January 23, 2019

Roche Launches uPath Enterprise Software with Improved Speed, Performance and Usability for Digital Pathology

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new standard of... Read More
January 22, 2019

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options QIAGEN N.V. has announced... Read More
January 22, 2019

Genetic Alliance and LunaPBC Partner to Support Personal Health and Accelerate Medical Breakthroughs

LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, announced today its partnership with Genetic Alliance, a non-profit dedicated to providing... Read More
January 22, 2019

XIFIN Enters Precision Medicine Informatics Market with the Launch of VisualStrata®

XIFIN, Inc. has unveiled VisualStrata, the only precision medicine informatics platform that curates and visualizes diagnostic, clinical and financial data to document the patient... Read More
November 27, 2018

Genomenon announced that it has published the first Cited Variant Reference (CVR)

Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The... Read More
April 23, 2018

BIO2018: Robin Roberts, Diana Ross and Record-breaking Partnering

As BIO celebrates its 25-year anniversary, the upcoming BIO International Convention June 4-7 at the Boston Convention and Exhibition Center will highlight the organization’s... Read More
April 18, 2018

LifeX™ Health Solutions Platform Opens Headquarters – Announces $2 million Henry L. Hillman Foundation grant

LifeX™, as part of Life Sciences Week 2018, celebrated the opening of its first headquarters, where it will provide expertise and working space to... Read More
April 18, 2018

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network

One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too... Read More
1 2 3 16